Butabarbital → 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-propenyl)-

HRID 2163115

Reaction equation

C[C@H](NC)[C@H](O)C1C=CC=CC=1.Cl.C[C@H](NC)[C@H](O)C1C=CC=CC=1.C[C@H](NC)[C@H](O)C1C=CC=CC=1.OS(O)(=O)=O.[CH3:43][CH2:44][CH:45]([C:47]1([CH2:56][CH3:57])[C:54](=[O:55])[NH:53][C:51](=[O:52])[NH:50][C:48]1=[O:49])C>>[CH2:45]([C:47]1([CH2:56][CH3:57])[C:48](=[O:49])[NH:50][C:51](=[O:52])[NH:53][C:54]1=[O:55])[CH:44]=[CH2:43]

Participants

Reactant 3

HCID 2479Butabarbital

HCID 65326Ephedrine Hydrochloride

HCID 5359318Ephedrine Sulfate

Product 1

HCID 485422,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-propenyl)-

Procedure

The composition of claim 1 containing 4 to 25 mg. of ephedrine hydrochloride or ephedrine sulfate and from 2 to 15 mg. of butabarbital per 5 milliliters of elixir.

Sources & evidence

ORD record: ord-b12355e6176f4d80a686001131d56520
Source dataset: uspto-grants-1979_01
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: USRE029875

Linked notes

Loading…